These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11428437)

  • 41. Immune response of varicella vaccinees to different varicella-zoster virus genotypes.
    Sauerbrei A; Stefanski J; Gruhn B; Wutzler P
    Vaccine; 2011 May; 29(22):3873-7. PubMed ID: 21459174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Varicella Virus Vaccination in the United States.
    Shaw J; Gershon AA
    Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospects for use of a varicella vaccine in adults.
    Hardy IR; Gershon AA
    Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
    Sauerbrei A; Wutzler P
    Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.
    Balbi O; Baldi S; Rizza S; Pietroiusti A; Perrone S; Coppeta L
    Hum Vaccin Immunother; 2021 Feb; 17(2):372-376. PubMed ID: 32643520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers.
    Lerman Y; Chodick G; Tepper S; Livni G; Ashkenazi S
    Epidemiol Infect; 2004 Dec; 132(6):1135-8. PubMed ID: 15635972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experience with the live Oka-strain varicella vaccine in children with solid tumours.
    Heath RB; Malpas JS
    Postgrad Med J; 1985; 61 Suppl 4(721):107-11. PubMed ID: 3014467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A long-term prospective study of varicella vaccine in healthy children.
    Johnson CE; Stancin T; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1997 Nov; 100(5):761-6. PubMed ID: 9346974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
    Gershon AA; Steinberg S; Gelb L; Galasso G; Borkowsky W; LaRussa P; Ferrara A
    Postgrad Med J; 1985; 61 Suppl 4():73-8. PubMed ID: 3014482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Protective effect of vaccination against chickenpox].
    Plesník V; Príkazský V; Pĕtvaldská L
    Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):143-7. PubMed ID: 11188760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
    Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
    Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advantage of a two-dose versus one-dose varicella vaccine in healthy non-immune teenagers and young adults.
    Kosuwon P; Sutra S; Kosalaraksa P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):697-701. PubMed ID: 15689090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers.
    Maple PA; Breuer J; Quinlivan M; Kafatos G; Brown KE
    J Clin Virol; 2012 Mar; 53(3):201-7. PubMed ID: 22261123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
    Gershon AA; Gershon MD; Shapiro ED
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S387-S397. PubMed ID: 34590140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.